American Thoracic Society

Out of the Blue: An AJRCCM Podcast

Health EN ↓ 198 episodes

The Out of the Blue podcast takes you out of the pages of the American Journal of Respiratory and Critical Care Medicine and into the minds of the most brilliant researchers in the fields of respiratory, critical care, and sleep medicine.

Author

American Thoracic Society

Category

Health

Podcast website

www.atsjournals.org

Latest episode

Jun 18, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline 03.04.2025

Dr. John Fleetham chats with Dr. Sonal Munsiff and Dr. Raquel Duarte about their article, " Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline ." 

Using Isoniazid More Safely and More Effectively in Tuberculosis Treatment 20.03.2025

Dr. John Fleetham chats with Dr. Paolo Denti, Dr. Elisa Ignatius, Dr. Jason Andrews, and Dr. Neil Schluger about two papers and an editorial published in AJRCCM discussing the use of isoniazid in treating patients with tuberculosis.

A Randomized Controlled Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea 13.03.2025

Dr. John Fleetham chats with Dr. Hedner and Dr. Schmickl about their articles “ A Randomized Controlled Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea " and  “ Drug Therapy for Obstructive Sleep Apnea: Are We There Yet? ” 

Progressive Early Interstitial Lung Abnormalities in Persons At-Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study and Big Things Have Small Beginnings: Clinical Implications of Early Interstitial Lung Disease 20.02.2025

Dr. Mohleen Kang chats with Dr. Margaret Salisbury and Dr. Anna Podolanczuk about their articles, " Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study " and " Big Things Have Small Beginnings: Clinical Implications of Early Interstitial Lung Disease ." 

Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official American Thoracic Society Research Statement 13.02.2025

Dr. John Fleetham chats with Dr. Yet Kor about her article, " Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official American Thoracic Society Research Statement ."

Hypnotics on Obstructive Sleep Apnea Severity and Endotypes: A Systematic Review and Meta-Analysis and The Arousal Threshold: The ‘Weakest Link’ in OSA Pathogenesis? 13.12.2024

Dr. John Fleetham chats with Dr. Ludovico Messineo and Dr. Simon Joosten about their articles " Hypnotics on Obstructive Sleep Apnea Severity and Endotypes: A Systematic Review and Meta-Analysis " and " The Arousal Threshold: The ‘Weakest Link’ in OSA Pathogenesis ." 

Evaluation of Etomidate Use and Association with Mortality Compared with Ketamine among Critically Ill Patients 06.12.2024

Dr. Michael Lanspa chats with Dr. Hannah Wunsch about her paper, " Evaluation of Etomidate Use and Association with Mortality Compared with Ketamine among Critically Ill Patients ."

From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations for Developing Precision Medicine in the ICU 11.10.2024

Dr. Michael Lanspa chats with Dr. Anthony Gordon about his article, " From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations for Developing Precision Medicine in the ICU ."

Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease 13.09.2024

Dr. John Fleetham chats with Dr. Chris Ryerson and Dr. Yet Khor about their article, " Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease ."

Senolytic-facilitated Reversal of End-Organ Dysfunction in a Murine Model of Obstructive Sleep Apnea 05.06.2024

Dr. John Fleetham chats with Dr. Gozal on his article, " Senolytic-facilitated Reversal of End-Organ Dysfunction in a Murine Model of Obstructive Sleep Apnea ."

Effectiveness of Fludrocortisone Plus Hydrocortisone Versus Hydrocortisone Alone in Septic Shock: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials 28.03.2024

Dr. John Fleetham chats with Dr. Bijan Teja and Dr. Nicholas Bosch about their article, " Effectiveness of Fludrocortisone Plus Hydrocortisone Versus Hydrocortisone Alone in Septic Shock: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials ." 

Inhalable Textile Microplastic Fibers Impair Airway Epithelial Differentiation and Inhaled Microplastics and Airway Development: Concerning Evidence from Organoids 21.02.2024

Dr. John Fleetham chats with Dr. Barbro N Melgert and Dr. Chris Carlsten about their articles, " Inhalable Textile Microplastic Fibers Impair Airway Epithelial Differentiation " and " Inhaled Microplastics and Airway Development: Concerning Evidence from Organoid s."

A New Global Definition of Acute Respiratory Distress Syndrome 17.01.2024

Dr. Michael Lanspa chats with Dr. Michael Matthay about his article, " A New Global Definition of Acute Respiratory Distress Syndrome ."

External Control Arms in Idiopathic Pulmonary Fibrosis Using Clinical Trial and Real-World Data Sources and The Added Power of Synthetic Control Groups: Challenging Conventional Wisdom and Trial Design in Idiopathic Pulmonary Fibrosis Research 16.01.2024

Dr. Mohleen Kang chats with Dr. Aparna Swaminathan and Dr. Timothy Dempsey about their articles, " External Control Arms in Idiopathic Pulmonary Fibrosis Using Clinical Trial and Real-World Data Sources ” and “ The Added Power of Synthetic Control Groups: Challenging Conventional Wisdom and Trial Design in Idiopathic Pulmonary Fibrosis Research .” 

The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial and Pharmacologic Therapy for Obstructive Sleep Apnea: Are We Seeing Some Light at the End of the Tunnel? 08.12.2023

Dr. John Fleetham chats with Dr. Paula K. Schweitzer and Dr. Najib Ayas about their articles, " The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial " and " Pharmacologic Therapy for Obstructive Sleep Apnea: Are We Seeing Some Light at the End of the Tunnel? "

FEV1/FVC Severity Stages for Chronic Obstructive Pulmonary Disease 05.10.2023

Dr. John Fleetham chats with Dr. Surya Bhatt about his article, “ FEV1/FVC Severity Stages for Chronic Obstructive Pulmonary Disease .”

Conservative versus Liberal Oxygenation Targets in Intensive Care Unit Patients (ICONIC): A Randomized Clinical Trial 28.09.2023

Dr Michael Lanspa chats with Dr. Imeen van der Wal and Dr. Chloe Grim on their article, " Conservative versus Liberal Oxygenation Targets in Intensive Care Unit Patients (ICONIC): A Randomized Clinical Trial ." 

Pulse Wave Amplitude Drops Index: A Biomarker of Cardiovascular Risk in Obstructive Sleep Apnea 20.07.2023

Dr. John Fleetham chats with Dr. Raphael Heinzer about his article, " Pulse Wave Amplitude Drops Index: A Biomarker of Cardiovascular Risk in Obstructive Sleep Apnea ."

Individualized Treatment Effects of Bougie vs Stylet for Tracheal Intubation in Critical Illness 22.06.2023

Dr. Michael Lanspa chats with Dr. Kevin Seitz and Dr. Matthew Churpek about their article, " Individualized Treatment Effects of Bougie vs Stylet for Tracheal Intubation in Critical Illness ."

Effectiveness of Bedaquiline Use Beyond Six Months in Patients with Multidrug-Resistant Tuberculosis 11.05.2023

Dr. John Fleetham chats with Dr. Molly Franke and Dr. James Brust about their articles, " Effectiveness of Bedaquiline Use Beyond Six Months in Patients with Multidrug-Resistant Tuberculosis " and “Weighting” the evidence: How much bedaquiline is enough? "

Dexmedetomidine and Propofol Sedation in Critically Ill Patients and Dose Associated 90-day Mortality: A Secondary Cohort Analysis of a Randomized Controlled Trial (SPICE-III) 23.03.2023

Dr. Michael Lanspa chats with Dr. Yahya Shehabi about his article, " Dexmedetomidine and Propofol Sedation in Critically Ill Patients and Dose Associated 90-day Mortality: A Secondary Cohort Analysis of a Randomized Controlled Trial (SPICE-III) ."

Tuberculosis Diagnoses Following Wildfire Smoke Exposure in California 02.03.2023

Dr. John Fleetham chats with Dr. Joseph Lewnard and Dr. Will Checkley about their articles, " Tuberculosis Diagnoses Following Wildfire Smoke Exposure in California " and " Tuberculosis, Wildfires, and Case-crossover Studies: An Epidemiological Trifecta. "

Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results 15.12.2022

Paper discussed in today's episode: Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results

Cardiovascular Benefit of Continuous Positive Airway Pressure in Adults with Coronary Artery Disease and Obstructive Sleep Apnea without Excessive Sleepiness 01.12.2022

Papers discussed in today's episode: Cardiovascular Benefit of Continuous Positive Airway Pressure in Adults with Coronary Artery Disease and Obstructive Sleep Apnea without Excessive Sleepiness Continuous Positive Airway Pressure and Cardiovascular Risk Reduction in Patients without Excessive Sleepiness: Importance of the Pulse Rate Response

High-Flow Versus VenturiMask Oxygen Therapy to Prevent Re-Intubation in Hypoxemic Patients After Extubation: A Multicenter, Randomized Clinical Trial 24.11.2022

Paper discussed in today's episode: High-Flow Versus VenturiMask Oxygen Therapy to Prevent Re-Intubation in Hypoxemic Patients After Extubation: A Multicenter, Randomized Clinical Trial

Listen to the Out of the Blue: An AJRCCM Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.